Yet, although miRNA profiling in the current study revealed the dysregulation of multiple immune-related miRNAs in DUX4-expressing muscle, none of these were validated as circulating FSHD biomarkers. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.